GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1004 participants.

Also called NCT05693545

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 1,004 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05693545
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Uganda (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05693545. Randomized; single masking; primary purpose treatment. Start 2023-09-01 (actual); primary completion 2026-10-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial
Condition
Rheumatic Heart Disease
Intervention (Drug)
phenoxymethyl penicillin
Intervention (Drug)
intramuscular benzathine penicillin G (BPG) prophylaxis
Lead sponsor
Children's Hospital Medical Center, Cincinnati (class: other)
Collaborator
Uganda Heart Institute (class: other)

Record details

Record id
cardio:ct-nct05693545
Content hash
b4cc6c728d17ee37d7dad350a2fa84bbd63cb39bb3fd32ce01307c7394d8cd4e